Molbio Diagnostics IPO
LISTEDMolbio Diagnostics Ltd · Mainboard IPO · NSE · Pharmaceutical
Price Band
₹765 – ₹807
Issue Size
₹940 Cr
Lot Size
18
GMP UNOFFICIAL
₹116 (14.4%)
Subscription
7.00x
About Molbio Diagnostics Ltd & Business Model
Molbio Diagnostics is an Indian medical technology company known for Truenat — portable real-time PCR testing devices.
Business Operations & Revenue Model
Molbio Diagnostics Ltd operates a scalable business model focused on value creation within Pharmaceutical. Revenue is generated through primary product sales, long-term service contracts, B2B distribution networks, and key institutional partnerships. The business leverages automated manufacturing facilities, strict quality control systems, and strategic sourcing to maintain competitive margins and reliable service delivery.
Products & Key Services
1. Core Product & Service Offerings: Comprehensive product lines engineered for Pharmaceutical standards. 2. Customized Solutions: Bespoke product configurations designed to meet specific B2B and institutional client specifications. 3. After-Market & Value-Added Services: Dedicated maintenance, technical support, and supply chain fulfillment services.
Promoters & Corporate Leadership
Molbio Diagnostics Ltd is led by experienced promoters with extensive industry track records and strategic governance capabilities. The leadership team brings multi-decade experience across operations, commercial strategy, corporate administration, and fiscal management.
Objects of the Issue (IPO Objectives)
The company proposes to utilize the Net Fresh Issue proceeds for the following primary objectives: 1. Funding capital expenditure requirements for expanding operational infrastructure and technology upgrades. 2. Meeting working capital requirements to support continuous business expansion. 3. Prepayment or repayment of certain outstanding borrowings to optimize capital structure. 4. General corporate purposes and strategic growth initiatives.
IPO Details & Terms
Strengths & Risks
✅ Strengths
- •Established market presence and strong brand recognition in Pharmaceutical.
- •Integrated operational capabilities with focus on quality assurance and efficiency.
- •Diversified customer base reducing revenue concentration risk.
- •Experienced promoter and management team with strong domain expertise.
- •Scalable operational architecture positioned for future expansion.
⚠️ Risks
- •Fluctuations in key raw material availability and pricing could impact gross operating margins.
- •Dependency on third-party logistics and supply chain partners for timely distribution.
- •Intense market competition from both domestic established players and new entrants in Pharmaceutical.
- •Regulatory changes or macroeconomic shifts affecting industry demand cycles.
- •Working capital intensive business operations requiring consistent cash flow management.
🚀 Opportunities
- •Expansion into high-growth regional and export markets.
- •Introduction of innovative product lines targeting evolving customer preferences in Pharmaceutical.
- •Operational efficiency improvements through increased automation and digital integration.
Frequently Asked Questions
What is Molbio Diagnostics IPO?
Molbio Diagnostics IPO is an IPO by Molbio Diagnostics Ltd (Pharmaceutical sector). Price band is ₹765 – ₹807 with an issue size of ₹940 Cr.
What is the minimum investment for Molbio Diagnostics IPO?
The minimum retail investment for Molbio Diagnostics IPO is approximately ₹14,526 (1 lot of 18 shares at the upper price band).
When is the Molbio Diagnostics IPO allotment date?
The official allotment date for Molbio Diagnostics IPO is 13 Aug 2026. Check allotment status with PAN on the registrar portal (Link Intime India Pvt Ltd).
When is the Molbio Diagnostics IPO listing date?
Molbio Diagnostics IPO is scheduled to list on 17 Aug 2026 on NSE.
What is Molbio Diagnostics IPO IPO GMP today?
The latest recorded Grey Market Premium (GMP) for Molbio Diagnostics IPO is ₹116 (14.4%). Note that GMP is an unofficial market sentiment indicator and does not guarantee listing price.
Key Dates
Check Allotment Status
Verify your allotment on the official registrar website. Never share OTP or passwords.
Check on Link Intime India Pvt Ltd →GMP (Grey Market Premium) is an unofficial, unregulated indicator. It does not guarantee the listing price. All IPO information is for educational purposes only. Verify from official SEBI/NSE/BSE sources.